AKT1 and breast carcinoma: Suppression of P13K/Akt pathway was also demonstrated in other cell lines like breast cancer cell HCC1937 [76], SkBr3 cells [77], liver cancer cell HepG2 [71], and HL-60 leukemia [19], upon quercetin treatment.